Biggest News Aggregation in the World
📰 Alfasigma News

Alfasigma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alfasigma. Real-time updates on events, politics, business and more.

Galapagos Agrees To Sell Jyseleca To Alfasigma

Galapagos NV (GLPG), a bio-pharmaceutical company, Tuesday said it entered into a deal to sell its Jyseleca business to Italian pharma company Alfasigma. As per the terms of the agreement, Michele Manto the Chief Commercial Officer of the company has resigned and will be joining Alfasigma in the same capacity.
United Kingdom Michele Manto Chief Commercial Officer United Kingdom Marketing Authorizations Galapagos Nv Bio Pharmaceutical Company

Alfasigma S.p.A. successfully completes tender offer for all outstanding shares of common stock of Intercept Pharmaceuticals, Inc.

BOLOGNA, Italy, November 08, 2023--Alfasigma S.p.A. ("Alfasigma") announced today that it has, through its wholly owned subsidiary Interstellar Acquisition Inc. ("Interstellar"), successfully completed its tender offer to purchase all outstanding shares of common stock of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) ("Intercept"), at a price of USD 19.00 per share, net to the seller thereof in cash, without interest, less any applicable withholding of taxes.
Trezzano Rosa Comunidad Autonoma De Cataluna United States Gea Gardini Luca Bolzoni Jemma Hodges
Source: yahoo.com

Alfasigma S.p.A. Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Pending Acquisition of Intercept Pharmaceuticals, Inc.

BOLOGNA, Italy, October 26, 2023--Alfasigma S.p.A. ("Alfasigma") today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") with respect to Alfasigma’s proposed acquisition of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) ("Intercept") expired at 11:59 p.m. on October 25, 2023. The expiration of the HSR Act waiting period satisfies one of the conditions to consummate the tender offer. Other...
United States Comunidad Autonoma De Cataluna Trezzano Rosa Emma Valgimigli Luca Bolzoni Jemma Hodges
Source: yahoo.com

After NASH Hopes Are Dashed, Intercept Pharma Agrees to $794M Buyout

Intercept Pharmaceuticals’ acquisition by Alfasigma comes three months after the FDA again rejected the biotech’s drug as a treatment for the fatty liver disease NASH. But Intercept still has rare liver disease assets, and Italy-based Alfasigma says acquiring the company will help it expand in gastroenterology and hepatology.
New Jersey United States New York Francesco Balestrieri Roberto Pellicciari University Of Perugia

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cision Portugal SA: Italian pharmaceutical company Alfasigma launches diagnostic drug Lumeblue ahead of World Digestive Health on 29 May

- WDHD 2022 is dedicated to raising awareness on colorectal cancer prevention - In Europe more than 519,820 new cases of colorectal cancer (CRC) were diagnosed in 2020 - Adenoma detection
United Kingdom Alessandro Repici Michal Kaminski Prateek Sharma Cosmo Pharmaceuticals Prnewswire Ahead Of World Digestive Health

Alfasigma: It's Vein Week from 5th to 11th of April

Share this article Share this article v-WIN Foundation and Alfasigma together to fight one of the leading causes of preventable death: venous thrombosis Italy as the hub of an international public awareness project on venous and lymphatic health of the legs to be presented in DUBAI during the EXPO An innovative geo-localization software has being launched to increase knowledge & awareness about the disease BOLOGNA, Italy, April 1, 2021 /PRNewswire/ --  Venous-lymphatic World International Netw...
United Arab Emirates Vincenzo Colli Yung Wei Chi Oscar Bottini Sergio Gianesini World International Network Foundation

Alfasigma: Jacopo Murzi is the new General Manager of the Italy Business Unit

Alfasigma: Jacopo Murzi is the new General Manager of the Italy Business Unit Murzi comes with extensive international experience He will lead the Italian team of Alfasigma bringing together the Pharma Italy and Consumer Health Care divisions BOLOGNA, Italy, March 9, 2021 /PRNewswire/ -- Jacopo Murzi, 49, joins Alfasigma Spa as General Manager of the Italy Business Unit which today includes the Pharma Italy, Consumer Healthcare, Commercial Operations, Market Access and BU Diversified division...
United States Vincenzo Colli Kostenloser Wertpapierhandel Jacopo Murzi Prnewswire Jacopo Murzi Roberto Mazzucato

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science